item management s discussion and analysis of financial condition and results of operations results of operations operating revenues compared to operating revenues were  for the year ended december   or higher than the year ended december  the increase in operating revenues was primarily attributable to improved service levels  improvements in the company s distribution network  the development of new sales and marketing programs and the expansion of the company s product lines 
during  the company introduced over new products including the temco deluxe four wheel walkabout  the john bunn nebulite ii medication compressor and the labtron automatic wrist blood pressure monitor 
in addition  revenues also include approximately  net of elimination of intercompany sales  attributable to the acquisition of national medical excess corp  effective as of july  the revenue increase was achieved despite the decline in sales to apria of for the year ended december  as compared to the prior year 
the company s supply agreement with apria terminated on december  during and  the company s product sales to apria were approximately million and million  respectively  which represented approximately and  respectively  of the company s product sales 
the company s sales to apria generated gross profit margins of approximately  which is significantly lower than the company s sales to its other customers which generate gross profit margins of approximately 
management believes that the company has implemented steps which could positively impact revenues and profits for  including improved customer service and efficiency levels  the introduction of new product lines and the expansion of its cap program 
however  no assurances can be given that such steps will produce sufficient revenues in to cover the decrease in revenues to apria 
compared to operating revenues were  for the year ended december   or higher than the year ended december  the increase in revenues reflected the partial recovery of certain revenues affected by past service and efficiency problems associated with the company s reorganization of its distribution network 
in addition  the increase was also attributable to the company s continued expansion of its product lines resulting from new and expanded distribution agreements with vendors 
interest and other income compared to interest and other income increased from  in to  in the increase is primarily due to the receipt of approximately  relating to an insurance recovery and a favorable settlement of a contractual dispute 
compared to interest and other income increased from  in to  in  an increase of due to higher interest rates 
cost of revenues compared to cost of revenues as a percentage of operating revenue remained relatively unchanged from the prior year  at 
due to manufacturing efficiencies and improved purchasing activities  the company maintained its gross profit margin despite increased competition 
compared to cost of revenues as a percentage of operating revenue decreased to from 
the decrease in cost of revenues was primarily the result of manufacturing efficiencies and improved purchasing activities during the period and non recurring costs of approximately  incurred during selling  general and administrative expenses compared to selling  general and administrative expenses decreased  or in as a percentage of operating revenues  selling  general and administrative expenses decreased to from 
the decrease was primarily due to cost reduction programs  the continued efficiencies generated by the company s distribution network and investments in new business systems  and the non recurring cost of approximately  recorded in the fourth quarter of compared to selling  general and administrative expenses increased  or in as a percentage of operating revenue  selling  general and administrative expenses remained at 
the increase was the result of additional depreciation and amortization primarily due to the company s investment in new equipment and systems and non recurring costs of approximately  which were incurred during the fourth quarter of the non recurring costs incurred were related to the estimated impairment of the residual value of the company s investment in a leveraged lease of  relating to certain changes in market conditions and technological advancements  an accrual for severance and other employee costs of approximately  related to employees terminated during the fourth quarter of and first quarter of  an accrual for sales and franchise taxes of approximately  related to audits conducted by multiple states for the periods through  and costs of approximately  related to a terminated acquisition and a lease arbitration proceeding involving the company s principal manufacturing facility 
management believes that such additional costs were non recurring 
interest expense compared to interest expense increased  or  principally due to an increase in interest rates from the prior year 
interest expense for the last six months of decreased compared to the same period in the prior year due to a decrease in borrowings during the period 
the company reduced its borrowings as a result of increased earnings  and the net proceeds of  realized from an offshore private placement of  shares of common stock completed in september compared to interest expense increased  or primarily due to an increase in interest rates in and an increase in borrowings used to finance the company s investment in warehousing equipment and new systems  and higher accounts receivable and inventory balances to support the increase in revenues 
net income compared to income before income taxes was  as compared to a loss before income taxes of  for the prior year 
the increase in income before income taxes is primarily due to the increase in revenues and the decrease in selling  general and administrative expenses 
net income was  as compared to a net loss of  for the prior year 
the company recorded income tax expense of  for the year ended december   as compared to an income tax benefit of  for the prior year 
as of december   the company recorded a deferred tax asset of  primarily comprised of net operating loss carryforwards and investment  research and development  jobs tax and alternative minimum tax credits 
based upon the company s expectation that future taxable income will be sufficient to utilize the carryforwards prior to december   the company has not recorded a valuation allowance on these deferred tax assets  except for an allowance of  related to tax assets recorded for acquired carryforwards 
future taxable income is expected to be derived from the company s existing operations and a tax planning strategy which anticipates the recognition of a taxable gain on the sale of appreciated assets which was consumated on march  the total deferred tax asset will continue to be evaluated by management as to its realizability on a quarterly basis 
the amount of the deferred tax asset considered realizable could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced 
uncertainties which may impact the future realizability but are not expected to occur  include a decline in sales and margins resulting from a possible loss of market share and increased competition 
compared to loss before income taxes and cumulative effect of change in accounting principle was  for as compared to  for the prior year 
the decrease in the loss before income taxes and cumulative effect of change in accounting principle is primarily the result of a partial recovery of certain revenue affected by past service and efficiency problems associated with the company s reorganization of its distribution network and the increase in gross profit margin resulting from manufacturing and purchasing efficiencies  partially offset by the increase in selling  general and administrative expenses and interest expenses 
net loss for was  as compared to a net loss  after the cumulative effect of a change in accounting for income taxes recorded in of  of  as permitted by fasb statement no 
 accounting for income taxes  the company recognized a deferred tax benefit of  resulting primarily from future tax benefits expected to be realized from the utilization of net operating loss carryforwards generated in the period 
based upon the company s tax planning strategy which anticipates the recognition of a taxable gain on the sale of appreciated assets and the expectation at december  that future taxable income would exceed approximately  prior to december   this deferred tax benefit was recorded 
the company has recorded a valuation allowance of  related to tax assets recorded for acquired carryforwards 
the company s business has not been materially affected by inflation 
liquidity and capital resources the company had working capital of   and  at december   and  respectively 
the increase in working capital for the period ended december  is primarily attributable to the cash provided by the company s net income of  which reflects  of depreciation and amortization expense 
in addition  the company raised  of additional capital  net of expenses  through an offshore private placement of  shares of its common stock completed in september  the decrease in working capital for the period ended december  is primarily due to the operating loss  principal payments on long term debt  and purchases of property  plant and equipment 
cash used in operations for the year ended december  was  the principal reason for the cash used in operations was the company s increase in accounts receivable due partially to the increase in revenue in the fourth quarter of as compared to the fourth quarter of  and the reduction of acceptances payables 
at december   the company had an unsecured line of credit with a bank available for letters of credit  acceptances and short term borrowings 
the total amount available under the line of credit is  the line is available for direct borrowings in an amount of up to  and provides for commercial letters of credit and bankers acceptances 
credit availability under this line is subject to the bank s continuing satisfaction with current financial information 
although the line of credit by its terms expires on june   the company anticipates that the line of credit will be renewed 
interest on direct borrowings is payable at the bank s prime rate plus  acceptances are created for a fee of above the bank s acceptance rate  and commercial letters of credit have a commission rate of per drawing 
at december  and  the company had direct borrowings of  and  respectively  utilized under the line 
at december  and   and  respectively  had been utilized under acceptances payable 
open letters of credit at december  relating to vendor purchases were  the company anticipates that the cash flow from operations  together with the current cash balance  and the anticipated renewal of its bank line of credit will be sufficient to meet its working capital requirements 
financing on march   the company privately sold at par to john hancock its guaranteed senior notes due february   in the aggregate principal amount of  and five year warrants to purchase  shares of the common stock of the company at an exercise price of per share 
during  the note agreement was amended to modify the terms of certain financial covenants and the terms of the warrants issued to john hancock 
the amendment to the note agreement provided for  among other things  an increase in the number of shares available for issuance under the warrants from  shares to  shares of the common stock of the company the initial warrants  a reduction in the exercise price of the warrants from to per share  and an extension of the expiration date of the warrants to february  the warrants  which were revalued as of the date of the amendment  have been valued at  and are being amortized as additional interest over the remaining term of the debt 
at december   the note agreement was amended to modify the terms of certain financial covenants 
in connection with the amendment  the company issued to john hancock additional warrants to purchase  shares of the common stock of the company the additional warrants at an exercise price of per share  with an expiration date of february  the company valued these warrants at  which will be amortized as additional interest over the remaining term of the related debt 
as a result of the offshore private placement of  shares of common stock in september  additional warrants to purchase  shares of the common stock of the company were issued to john hancock  and the exercise prices of the warrants were adjusted from per share to per share with respect to the initial warrants  and from per share to per share with respect to the additional warrants 
the guaranteed senior notes are unsecured  guaranteed by the company s significant subsidiaries  rank pari passu with all future and current indebtedness of the company  and are senior to all existing and future subordinated indebtedness of the company 
the note agreement contains provisions relating to mandatory and optional redemption  limitations with respect to the incurrence of debt  liens  transactions with affiliates  consolidations and mergers  sales of assets and dividends and other distributions 
in addition  the note agreement contains certain financial covenants including the maintenance of consolidated net worth  and fixed charge and interest expense ratios 
under the terms and provisions of the note agreement  the company is not permitted to declare or pay any dividends other than dividends paid in shares of its common stock or make any distribution to stockholders or any other restricted payments and restricted investments  in an amount greater than  plus of the company s cumulative consolidated net income after december  less of losses 
as of december   under the terms and provisions of the note agreement  the company was restricted from declaring and paying any cash dividends and making any other restricted payments and restricted investments 
in september  the company completed an offshore private placement of  shares of its common stock with various european institutional investors 
the net proceeds of  realized from the offering were used for general corporate purposes 
on march   the company sold its gentle expressions breast pump product line to the lumiscope company  inc for a purchase price of  of which  was paid in cash with the balance in a secured subordinated promissory note in the aggregate principal amount of  payable over months plus interest at the prime rate of interest plus 
under the terms of the transaction  lumiscope will purchase certain inventory of the gentle expressions breast pump product line over a six month period  and provide the company with a one year royalty based upon lumiscope s sales to a certain retail discount chain 
in addition  the company entered into a supply agreement with lumiscope pursuant to which lumiscope will continue to supply the gentle expressions product line to the company for resale to the export market and certain other accounts 
annual report on form k item  item a and  c and d list of financial statements and financial statement schedule financial statements certain exhibits financial statement schedule year ended december  graham field health products  inc 
hauppauge  new york form k item  item a and and d graham field health products  inc 
and subsidiaries list of financial statements and financial statement schedule the following consolidated financial statements of graham field health products  inc and subsidiaries are included in item report of independent auditors 

















f consolidated balance sheets december  and 



















f consolidated statements of operations years ended december   and 










f consolidated statements of stockholders equity years ended december   and 










f consolidated statements of cash flows years ended december   and 










f notes to consolidated financial statements december  























f the following consolidated financial statement schedule of graham field health products  inc and subsidiaries is included in item d schedule ii valuation and qualifying accounts 









f all other schedules for which provision is made in the applicable accounting regulation of the securities and exchange commission are not required under the related instructions or are inapplicable  and therefore have been omitted 
f report of independent auditors stockholders and board of directors graham field health products  inc we have audited the accompanying consolidated balance sheets of graham field health products  inc and subsidiaries as of december  and  and the related consolidated statements of operations  stockholders equity and cash flows for each of the three years in the period ended december  our audits also included the financial statement schedule listed in the index at item a 
these financial statements and schedule are the responsibility of the company s management 
our responsibility is to express an opinion on these financial statements and schedule based on our audits 
we conducted our audits in accordance with generally accepted auditing standards 
those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement 
an audit includes examining  on a test basis  evidence supporting the amounts and disclosures in the financial statements 
an audit also includes assessing the accounting principles used and significant estimates made by management  as well as evaluating the overall financial statement presentation 
we believe that our audits provide a reasonable basis for our opinion 
in our opinion  the consolidated financial statements referred to above present fairly  in all material respects  the consolidated financial position of graham field health products  inc and subsidiaries at december  and  and the consolidated results of their operations and their cash flows for each of the three years in the period ended december   in conformity with generally accepted accounting principles 
also  in our opinion  the related financial statement schedule  when considered in relation to the basic financial statements taken as a whole  presents fairly in all material respects the information set forth therein 
ernst young llp melville  new york march  f graham field health products  inc 
and subsidiaries consolidated balance sheets december assets current assets cash and cash equivalents   accounts receivable  less allowance for doubtful accounts of  and  respectively   inventories   other current assets   recoverable and prepaid income taxes   total current assets   property  plant and equipment  net   excess of cost over net assets acquired  net of accumulated amortization of  and  respectively   investment in leveraged lease   deferred tax assets   other assets   total assets   see notes to consolidated financial statements 
f graham field health products  inc and subsidiaries consolidated balance sheets continued december liabilities and stockholders equity current liabilities note payable to bank   current maturities of long term   debt accounts payable   acceptances payable   accrued expenses   total current   liabilities long term debt   guaranteed senior notes   total liabilities   stockholders equity preferred stock  par value 
per share authorized shares  none issued common stock  par value 
per   share authorized shares  issued and outstanding  and  respectively additional paid in capital   deficit   commitments and contingencies total liabilities and   stockholders equity see notes to consolidated financial statements 
f graham field health products  inc 
and subsidiaries consolidated statements of operations year ended december net revenues medical equipment and supplies    interest and other income    costs and expenses cost of revenues    selling  general and administrative    interest expense    income loss before income taxes benefit and cumulative effect of change in accounting principle    income taxes benefit    income loss before cumulative effect of change in accounting principle    cumulative effect of change in accounting principle  net income loss    net income loss per share income loss before cumulative effect of change in accounting principle 


cumulative effect of change in accounting principle 
net income loss per share 


weighted average number of common and common equivalent shares    see notes to consolidated financial statements 
f graham field health products  inc 
and subsidiaries consolidated statements of stockholders equity common stock additional treasury stock paid in total shares amount capital deficit shares amount balance  december         issuance of common stock on exercise of stock options       compensation to employee    tax benefit from exercise of stock options   warrants issued in connection with debt   retirement of treasury stock      cumulative effect of change in accounting principle   net loss   balance  december       issuance of common stock on exercise of stock options       tax benefit from exercise of stock options   retirement of treasury stock      net loss   balance  december       issuance of common stock on exercise of stock options       regulation s offering  net     tax benefit from exercise of stock options   retirement of treasury stock     warrants issued in connection with debt   net income   balance  december       see notes to consolidated financial statements 
f graham field health products  inc 
and subsidiaries consolidated statements of cash flows year ended december operating activities net income loss    adjustments to reconcile net income loss to net cash used in provided by operating activities cumulative effect of change in  accounting principle depreciation and amortization    leveraged lease valuation adjustment  deferred income taxes    provisions for losses on accounts receivable    loss on disposal of property  plant and equipment  other   changes in operating assets and liabilities  net of effects of acquisition accounts receivable    inventories and other current assets    recoverable and prepaid income taxes    accounts and acceptances payable and accrued expenses    net cash used in provided by operating activities    investing activities purchase of short term investments   purchase of property  plant and equipment    proceeds from the sale of property  plant  and equipment  purchase of certain assets and liabilities of national medical excess corp  net of cash acquired  start up cost related to the st 
louis distribution center   decrease increase in other assets    net cash used in provided by investing activities    f graham field health products  inc and subsidiaries consolidated statements of cash flows continued year ended december financing activities proceeds from note payable to bank and long term debt    principal payments on revolving line of credit  long term debt and notes payable    proceeds on exercise of stock options    proceeds from issuance of common stock  net  net cash provided by used in financing activities    increase decrease in cash and cash equivalents    cash and cash equivalents at beginning of year    cash and cash equivalents at end of year    supplementary cash flow information interest paid    income taxes paid refunded    see notes to consolidated financial statements 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements december  summary of significant accounting policies description of business graham field health products  inc and its subsidiaries the company manufacture  market and distribute medical  surgical and a broad range of other health care products for hospital  physician and home use 
the company markets and distributes approximately  products under its own brand names and under suppliers names 
the company s products are marketed to approximately  customers  principally hospital  nursing home  physician and home health care dealers  health care product wholesalers and retailers primarily within the united states 
in addition  the company has increased its presence in central and south america  canada  mexico  europe and asia 
approximately of the company s revenues are derived from products produced by the company  and approximately are derived from products and components purchased from domestic sources 
approximately are derived from products and components purchased internationally  of which are from the far east and from europe and all other locations 
principles of consolidation the consolidated financial statements include the accounts of the company and its subsidiaries  each of which is wholly owned 
all material intercompany accounts and transactions have been eliminated in consolidation 
use of estimates the preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period 
actual results could differ from those estimates 
cash equivalents the company considers all highly liquid investments with a maturity of three months or less when purchased to be cash equivalents 
inventories inventories are valued at the lower of cost or market value 
cost is determined principally on the standard cost method for manufactured goods and on the average cost method for other inventories  each of which approximates actual cost on the first in  first out method 
property  plant and equipment property  plant and equipment is recorded at cost  less accumulated depreciation and amortization 
depreciation and amortization is computed on the straight line method over the lesser of the estimated useful lives of the related assets or the lease term  where appropriate 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements summary of significant accounting policies continued excess of cost over net assets acquired excess of cost over net assets acquired is generally amortized on a straight line basis over years 
the carrying value of such costs are reviewed by management as to whether the facts and circumstances indicate that an impairment may have occurred 
if this review indicates that such costs or a portion thereof will not be recoverable  as determined based on the undiscounted cash flows of the entities acquired over the remaining amortization period  the carrying value of these costs will be reduced by the estimated shortfall of cash flows 
revenue recognition policy the company recognizes revenue when products are shipped  with appropriate provisions for uncollectible accounts and credits for returns 
income taxes the company and its subsidiaries file a consolidated federal income tax return 
effective january   the company adopted fasb statement no 
 accounting for income taxes  which superseded fasb statement no 
see notes and 
net income loss per share information net income per common share for was computed using the weighted average number of common shares and dilutive common equivalent shares outstanding during the period 
net loss per common share for and was computed using the weighted average number of common shares outstanding during the period 
employee stock options the company has a stock option program which is more fully described in note the company accounts for stock option grants in accordance with apb opinion no 
 accounting for stock issued to employees  and  because the exercise price of the options equals the market price of the underlying common stock of the company on the date of grant  no compensation expense is recognized for the stock options 
concentration of credit risk the company manufactures and distributes health care products and medical sundries principally to hospitals  health care distributors and retailers 
the company performs periodic credit evaluations of its customers financial condition and generally does not require collateral 
receivables generally are due within to days 
credit losses relating to customers have been consistently within management s expectations 
recently issued accounting standards in march  the fasb issued statement of financial accounting standards sfas no 
 accounting for the impairment of long lived assets and for long lived assets to be disposed of 
this standard is effective for the company s financial statements beginning in the first quarter of sfas no 
establishes the accounting for the impairment of long lived assets  certain identifiable intangibles and the excess of cost over net assets acquired  related to those assets to be held and used in operations  whereby impairment losses are required to be recorded when indicators of impairment are present and the undiscounted cash flows estimated to be generated by those assets are less than the assets carrying amount 
sfas no 
also addresses the accounting for long lived assets and certain identifiable intangibles that are expected to be disposed of 
in the opinion of the company s management  it is anticipated that the adoption of sfas no 
will not have a material effect on the results of operations or financial condition of the company 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements summary of significant accounting policies continued in october  the fasb issued sfas no 
 accounting for stock based compensation  which requires adoption of the disclosure provisions no later than the fourth quarter of the new standard defines a fair value method of accounting for the issuance of stock options and other equity instruments 
under the fair value method  compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period  which is usually the vesting period 
pursuant to sfas no 
 companies are encouraged  but are not required  to adopt the fair value method of accounting for employee stock based transactions 
companies are also permitted to continue to account for such transactions under accounting principles board opinion no 
 accounting for stock issued to employees  but would be required to disclose in a note to the financial statements proforma net income and per share amounts as if the company had applied the new method of accounting 
sfas no 
also requires increased disclosures for stock based compensation arrangements 
the company has not yet determined if it will elect to change to the fair value method or provide the necessary proforma information  nor has it determined the effect the new standard will have on its operating and per share results should it elect to make such change 
change in accounting for income taxes in february  the fasb issued statement no 
 accounting for income taxes 
the company adopted the provisions of the new standard in its financial statements for the year ended december  the adoption of statement no 
did not affect the company s pretax loss from operations for the year ended december  the cumulative effect as of january  of adopting statement no 
was a tax benefit of  or 
per share which is net of allowances of  this tax benefit is principally attributable to available net operating loss carryforwards and investment  research and development  jobs tax and alternative minimum tax credits which can be used to reduce future tax liabilities 
additionally  the company recorded deferred tax assets of approximately  related to net operating loss carryforwards previously acquired in a prior acquisition and the exercise of non qualified stock options and disqualifying dispositions of incentive stock options which resulted in certain tax benefits see note 
the effect of recognizing these deferred tax assets under statement no 
was to reduce other assets by  and to increase additional paid in capital by  under statement no 
 the liability method is used in accounting for income taxes 
under this method  deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities  and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements acquisition of business effective july   the company acquired substantially all of the assets and liabilities of national medical excess corp 
nme  a distributor of used and refurbished medical products  including respiratory and durable medical equipment 
the nme acquisition was accounted for under the purchase method of accounting and accordingly  assets and liabilities were recorded at fair values at the date of acquisition 
results of operations of nme are included in the consolidated financial statements of the company subsequent to that date 
the purchase price  including acquisition expenses  was approximately  in cash  plus the assumption of certain liabilities 
the excess of cost over the net assets acquired amounted to approximately  inventories inventories consist of the following december raw materials   work in process   finished goods   property  plant and equipment property  plant and equipment consist of the following december equipment   furniture and fixtures   leasehold improvements   accumulated depreciation and amortization   the company recorded depreciation and amortization expense on the assets included in property  plant and equipment of   and  for the years ended december   and  respectively 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements investment in leveraged lease the company is the lessor in a leveraged lease agreement entered into in december  under which helicopters  having an estimated economic life of at least years  were leased for a term of years 
the company s equity investment represented of the purchase price  the remaining was furnished by third party financing in the form of long term debt that provides for no recourse against the company and is secured by a first lien on the property 
at the end of the lease term  the equipment is to be returned to the company 
the residual value was estimated to be of the cost 
as a result of certain market conditions and technological advancements  the company recorded a charge in the fourth quarter of of approximately  which was included in selling  general and administrative expenses  to reflect the estimated impairment of the residual value of the helicopters 
for federal income tax purposes  the company receives an investment tax credit  and has the benefit of tax deductions for depreciation on the entire leased asset and for interest on the long term debt 
during the early years of the lease  those deductions exceeded the lease rental income 
in the later years of the lease  rental income will exceed the deductions for federal income tax purposes 
accordingly  pursuant to fasb statement no 
 this represents a temporary difference for which the company has recorded a deferred tax liability see note 
the company s net investment in the leveraged lease is comprised of the following elements december rental receivables  net of the principal and interest on the nonrecourse debt   residual value   less unearned and deferred income   investment in leveraged lease   acceptances payable at december  and  the company had an unsecured line of credit with a bank available for letters of credit  acceptances and direct borrowings 
the total amount available under the line of credit is   at december  
the line was reduced from  to  during based on the anticipated needs of the company 
the line is available for direct borrowings in the amount of up to  and provides for commercial letters of credit and bankers acceptances 
credit availability under this line is subject to the bank s continuing satisfaction with current financial information 
the line of credit outstanding at december  expires on june  the company anticipates that the line of credit will be renewed 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements acceptances payable continued interest on direct borrowings is payable at the bank s prime rate at december  plus  acceptances are created for a fee of above the bank s acceptance rate  and commercial letters of credit have a commission rate of per drawing 
at december  and  the company had direct borrowings of  and  respectively  utilized under the line 
at december  and   and  respectively  had been utilized under acceptances payable 
the weighted average interest rate on the amounts outstanding as of december  and was and  respectively 
open letters of credit at december  relating to vendor purchases were  income taxes effective january   the company changed its method of accounting for income taxes in accordance with the liability method required by fasb statement no 
 accounting for income taxes see note 
as permitted under the new rules  prior years financial statements were not restated 
the cumulative effect of adopting statement no 
as of january  was a tax benefit of  the application of the new income tax rules did not affect the company s pretax loss from operations for the year ended december  at december   the company had net operating loss carryforwards of approximately  for income tax purposes which expire primarily in and  of which approximately  were acquired in connection with an acquisition and expire primarily in and are limited as to use in any particular year 
for financial reporting purposes  a valuation allowance of  has been recognized to offset the deferred tax assets related to those acquired carryforwards 
if realized  the tax benefit for those items will be recorded as a reduction in goodwill 
the company has not provided an additional valuation allowance against its net deferred tax asset recorded at december  based upon the company s tax planning strategy see note  which anticipates the recognition of a taxable gain on the sale of appreciated assets and the expectation that future taxable income will be sufficient during the carryforward period 
the amount of the deferred tax asset considered realizable could be reduced in the near term if estimates of future taxable income during the carryforward period are reduced 
in addition  at december   the company had approximately  net of a reduction of investment tax credits as a result of the tax reform act of of investment  research and development and jobs tax credits  for income tax purposes which expire primarily in  and which includes alternative minimum tax credits of  which have no expiration date 
in  the company recorded deferred state tax benefits previously not recognized as a component of the net operating loss carryforwards 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements income taxes continued deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes 
significant components of the company s deferred tax assets and liabilities as of december  and are as follows deferred tax assets net operating loss carryforwards   tax credits   accounts receivable and other reserves   uniform capitalization   deferred rent   other   valuation allowance for deferred assets   total deferred tax assets   deferred tax liabilities tax over book depreciation   leveraged lease   prepaid expenses   amortization of intangibles   other   total deferred tax liabilities   net deferred tax assets   significant components of the provision for income taxes are as follows current federal  state and local  benefit of net operating loss carryforwards  deferred federal and state    f graham field health products  inc 
and subsidiaries notes to consolidated financial statements income taxes continued the following is a reconciliation of income tax computed at the federal statutory rate to the provision for taxes before cumulative effect of change in accounting principle amount percent amount percent amount percent tax expense benefit computed at statutory rate    expenses not deductible for income tax purposes amortization of excess of cost over net assets acquired    other    state tax expense benefit  net of federal benefit    previously unrecognized state tax benefits  long term debt long term debt consists of the following december notes payable to international business machines corp 
ibm   other notes payable  less current maturities   f graham field health products  inc 
and subsidiaries notes to consolidated financial statements long term debt continued in connection with the development of the company s st 
louis distribution center  the company entered into an agreement with ibm to provide the computer hardware and software  and all necessary warehousing machinery and equipment including installation thereof 
this project was primarily financed through ibm in the form of individual unsecured notes which corresponded to various components of the project 
the total amount financed was approximately  of which approximately  remains outstanding at december  in march the company financed the upgrade of its existing computer system at a cost of  in september  such upgrade was refinanced partially through an operating lease with the balance of  refinanced with a new note payable  of which approximately  remains outstanding at december  the notes payable are summarized below december note payable with monthly principal and interest payments of  at per annum maturing march    note payable with monthly principal and interest payments of  at per annum maturing december   refinanced in september  note payable  related to partial refinancing of an upgrade  with monthly principal and interest payments of  at per annum maturing october   note payable with monthly principal and interest payments of  at per annum maturing july    note payable with monthly principal and interest payments of  at per annum maturing september    f graham field health products  inc 
and subsidiaries notes to consolidated financial statements long term debt continued the scheduled maturities of the above listed notes are as follows year ended december guaranteed senior notes on march   the company privately sold at par to john hancock its guaranteed senior notes due february   in the aggregate principal amount of  and five year warrants to purchase  shares of the common stock of the company at an exercise price of per share 
during  the note agreement was amended to modify the terms of certain financial covenants and the terms of the warrants issued to john hancock 
the amendment to the note agreement provided for  among other things  an increase in the number of shares available for issuance under the warrants from  shares to  shares of the common stock of the company the initial warrants  a reduction in the exercise price of the warrants from to per share  and an extension of the expiration date of the warrants to february  the warrants  which were revalued as of the date of amendment  have been valued at  and are being amortized as additional interest over the remaining term of the debt 
at december   the note agreement was amended to modify the terms of certain financial covenants 
in connection with the amendment  the company issued to john hancock additional warrants to purchase  shares of the common stock of the company the additional warrants at an exercise price of per share  with an expiration date of february  these warrants were valued at  and will be amortized as additional interest over the remaining term of the debt 
as a result of an offshore private placement of  shares of common stock in september  additional warrants to purchase  shares of the common stock of the company were issued to john hancock and the exercise prices of the warrants were adjusted from per share to per share with respect to the initial warrants and from per share to per share with respect to the additional warrants 
the guaranteed senior notes are unsecured  guaranteed by the company s significant subsidiaries  rank pari passu with all future and current indebtedness of the company  and are senior to all existing and future subordinated indebtedness of the company 
the note agreement  as amended  contains provisions relating to mandatory and optional redemption  limitations with respect to the incurrence of debt  liens  transactions with affiliates  consolidations and mergers  sales of assets and dividends and other distributions 
in addition  the note agreement  as amended  contains certain financial covenants including the maintenance of consolidated net worth  and fixed charge and interest expense ratios 
under the terms and provisions of the note agreement  as amended  the company is not permitted to declare or pay any dividends other than dividends paid in shares of its common stock or make any distribution to stockholders or any other restricted payments and restricted investments  in an amount greater than  plus of the company s cumulative consolidated net income after december  less of losses 
as of december   under the terms and provisions of the note agreement  as amended  the company was restricted from declaring and paying any cash dividends and making any other restricted payments and restricted investments 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements guaranteed senior notes continued in connection with the issuance and amendments to the guaranteed senior notes  issuance costs of approximately  and  net of accumulated amortization of  and  respectively  have been included in other assets at december  and such costs will be amortized over the term of the guaranteed senior notes 
the following is a schedule of maturities year ended december on february   the company paid the  installment on the guaranteed senior notes in accordance with the terms of the note agreement  as amended 
commitments and contingencies operating leases on january   the lease agreement for the company s hauppauge facility was amended to cover a period of seventeen years with one ten year renewal option 
under the hauppauge lease  the company pays an annual base rent of  in escalating to  through the seventeenth year and all related real estate taxes 
in march  the company entered into a new lease on its secondary hauppauge warehouse facility to cover a period of fifteen years starting on january   with two five year renewal options 
the new lease requires the payment of an annual base rent of approximately  in escalating to  through the fifteenth year and all related real estate taxes 
in march  the company entered into a lease agreement for the company s california facility for a period of six years  with one five year renewal option 
the lease requires the payment of an annual base rent of approximately  in escalating to  through the sixth year and all related real estate taxes 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements commitments and contingencies continued in march  the company entered into a lease agreement for its st 
louis  missouri distribution center for a period of fifteen years commencing april  the lease requires the payment of an annual base rents of  in the first year escalating to  through the fifteenth year and all incremental real estate taxes over a base year of the escalating rents may be adjusted by fluctuations in the consumer price index  however  in no event shall the base rent exceed  during years six through ten and  during the remaining five years 
the lease on the company s principal manufacturing facility was for a period of fifteen years commencing october   with an option to purchase the facility at the lessor s net book value at the end of the fifth  tenth  or fifteenth year 
in may  the company modified the lease to eliminate the purchase option  reduce the term to thirteen years with an option to renew for an additional two year period  and change the annual rent from  to  escalating to  on january  the lease requires the company to pay all related real estate taxes in addition to the annual base rent 
in march  the company entered into a lease agreement for office and warehouse facilities in mount vernon  new york for a period of three years 
the lease provides for the payment by the company of fixed annual rents of  for the first year escalating to  for years two and three and all incremental real estate taxes over the base year 
the company has an option to renew the lease for an additional three year period at a fixed annual rent of the company has recorded rent expense related to these leases on a straight line basis 
at december  and   and  respectively  of rent expense is accrued in excess of rental payments made 
the company also leases other facilities and machinery and equipment  including computer equipment under operating leases with unexpired terms ranging from one to five years 
as of december   minimal annual rental payments under all noncancellable operating leases are as follows year ended december thereafter  rent expense for the years ended december   and approximated   and  respectively 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements commitments and contingencies continued litigation the company is a defendant in certain legal actions which arose in the normal course of business  the outcome of which  in the opinion of management  will not have a material adverse effect on the company s financial position 
collective bargaining agreements the company is a party to two collective bargaining agreements with two unions 
each of the collective bargaining agreements is for a term of three years and covers all hourly employees  excluding supervisors  clerical and part time employees  in hauppauge  new york and passaic  new jersey 
the collective bargaining agreements for hauppauge  new york and passaic  new jersey expire on april  and july   respectively 
the company is in the process of renegotiating its hauppauge  new york collective bargaining agreement 
however  the negotiations still remain in the preliminary stages 
the company has never experienced an interruption or cur tailment of operations due to labor controversy  except for a three day period during the summer of in which the company experienced a strike at its passaic  new jersey facility which did not have a material adverse effect on the company s operations 
the company considers its employee relations to be satisfactory 
stockholders equity on march   the company declared  and on july  the stockholders approved  a dividend distribution to stockholders of record on july  of one right for each outstanding share of the company s common stock 
each right entitles the registered holder to purchase one one hundredth l of a share of series a participating preferred stock  
par value  at an exercise price of 
the exercise price payable and the number of preferred shares issuable upon exercise of the rights are subject to adjustment from time to time to prevent dilution  as defined 
the rights become exercisable days after a public announcement that a person or group of affiliated or associated persons  as defined  has acquired or obtained the right to acquire beneficial ownership of or more of the company s common stock  or days after commencement of a public announcement of a tender or exchange offer or take over bid to acquire beneficial ownership of or more of the company s common stock  or such later date as may be determined by the board of directors 
if a person or group of affiliates or associated persons shall become the beneficial owner of or more of the common stock of the company  other than pursuant to a tender or exchange offer for all outstanding common shares of the company that the board of directors of the company determines to be at a price and on terms that are fair to holders of shares of common stock of the company  each holder of a right  will have the right to receive  upon payment of one quarter of the exercise price  in lieu of preferred shares  a number of shares of common stock of the company having an aggregate market value equal to one half the exercise price 
in the event the company is acquired in a merger or other business combination in which any of the shares of common stock are changed into or exchanged for other securities or assets or more than of the assets or operating income or cash flow of the company and its subsidiaries are sold or transferred in one or a series of related transactions  each holder of a right shall have the right to receive  upon payment of the exercise price  that number of shares of common stock of the acquiring company which at the time of such transaction would have a market value equal to two times the exercise price 
the rights  which are nonvoting  expire on july  the rights may be redeemed by the company at a price of 
per right at any time prior to the earlier of their expiration date or days after a public announcement that a person or group of affiliates or associated persons has acquired or more of the company s common stock 
the rights attach to all shares of common stock  including treasury shares outstanding at july   and all shares issued subsequent to july  f graham field health products  inc 
and subsidiaries notes to consolidated financial statements stockholders equity continued the series a participating preferred shares are nonredeemable and subordinate to any other series of the company s preferred shares  which may at any time be issued 
the company does not have any preferred shares outstanding 
the preferred shares may not be issued except upon exercise of the rights 
during  officers of the company surrendered  shares of the company s common stock with a fair market value of  in exchange for the exercise of stock options held by them for  shares of common stock of the company at an exercise price of per share 
the  shares received were recorded and held as treasury stock by the company 
during and  in similar transactions   and  shares  respectively  of the company s common stock with a fair market value of  and  respectively  were surrendered and recorded as treasury stock in exchange for the exercise of stock options held for  and  shares  respectively  of common stock of the company at exercise prices ranging from to per share 
on march   the board of directors of the company approved the retirement of all shares of treasury stock held by the company at december  in addition  on october   the board of directors authorized the retirement of all shares of treasury stock held by the company at the end of each applicable quarter 
accordingly all such shares have been restored as authorized and unissued shares of common stock 
in september  the company completed an offshore private placement of  shares of its common stock with various european institutional investors 
the net proceeds of  realized from the offering were used for general corporate purposes 
the company has a stock option program which permits the granting of incentive stock options  nonqualified stock options  stock appreciation rights  restricted stock grants and restored options 
incentive stock options may be granted at not less than for owners of more than of the company s outstanding common stock of the fair market value of the company s common stock at the date of grant 
stock options outstanding under the program generally vest and are exercisable at a rate of per annum 
effective as of december   directors options to purchase  shares of the common stock of the company are granted to eligible directors each january  through january   at an exercise price equal to the fair market value of the common stock at the date of grant 
directors options are exercisable one third each year for three years 
incentive and non qualified options expire five years from the date of grant 
directors options expire ten years from the date of grant 
in  the company amended its stock option program which authorizes the issuance of shares or certain rights to acquire shares of the company s common stock to directors  officers and other key executives and management employees of the company 
the amendment increased the maximum number of shares that can be issued under this program from  to  in  the company amended its stock option program to increase the maximum number of shares that can be issued under this program from  to  f graham field health products  inc 
and subsidiaries notes to consolidated financial statements stockholders equity continued information with respect to options during the three years ended december  is as follows number of shares option price options outstanding at december   granted incentive options  directors options  nonqualified options  exercised  cancelled and expired  options outstanding at december   granted incentive options  directors options  nonqualified options  exercised  cancelled and expired  options outstanding december   granted incentive options  directors options  exercised  cancelled and expired  options outstanding at december   exercisable at end of year  shares available for future grants of options at end of year  shares reserved for future issuances as of december  are as follows number of shares stock options  stock options issued in connection with an acquisition  stock warrants issued to john hancock mutual life in connection with the company s guaranteed senior notes  f graham field health products  inc 
and subsidiaries notes to consolidated financial statements stockholder s equity continued the exercise of non qualified stock options and disqualifying dispositions of incentive stock options resulted in federal and state income tax benefits to the company equal to the difference between the market price at the date of exercise or sale of stock and the exercise price of the option 
accordingly  during  and  approximately   and  respectively  was credited to additional paid in capital 
disclosures about fair value of financial instruments the following methods and assumptions were used to estimate the fair value of each class of financial instruments as of december   for which it is practicable to estimate that value cash and cash equivalents the carrying amounts reported in the accompanying balance sheets approximate fair value 
investment in leveraged lease the carrying amounts reported in the accompanying balance sheets approximate fair value 
fair value is determined based on the current value of the underlying assets 
notes and acceptances payable the carrying amounts of the company s borrowings under its short term line of credit facility approximate their fair value 
long term debt the fair values of the company s long term debt are estimated using discounted cash flow analyses  based on the company s incremental borrowing rates for similar types of borrowing arrangements 
at december   the carrying amount reported approximates fair value 
guaranteed senior notes the fair value of the company s guaranteed senior notes is estimated using a discounted cash flow analysis based on current rates offered to the company for debt of the same remaining maturity 
at december   the fair value of such debt was approximately  other matters during the fourth quarter of  the company recorded non recurring expenses of approximately  which were included in selling  general and administrative expenses at december   of which approximately  was included in accrued expenses 
these non recurring expenses were related to the estimated impairment of the residual value related to the company s investment in leveraged lease see note  an accrual for severance and other employee costs related to employees terminated during the fourth quarter of and first quarter of  an accrual for sales and franchise taxes related to in process audits being conducted by multiple states for the periods of through  and costs related to a terminated acquisition attempt and a lease arbitration proceeding with respect to the company s principal manufacturing facility 
in addition  start up costs incurred for the design and implementation of the company s principal distribution facility  which approximated  and  which is net of accumulated amortization of  and  and have been included in other assets at december  and  respectively 
f graham field health products  inc 
and subsidiaries notes to consolidated financial statements major customers in  the company derived of its revenues from apria healthcare group  inc formerly abbey home healthcare  which merged with homedco in june 
on september   the company announced that its current supply agreement with apria would not be renewed in  and will expire by its terms on december  during fiscal year and  the company s product sales to apria were approximately million and million  respectively  which represented approximately and  respectively  of the company s product sales 
the company s sales to apria generate gross profit margins of approximately  which is significantly lower than the company s sales to its other customers which generate gross profit margins of approximately 
the company has implemented steps which could positively impact revenues and profits for fiscal year  including improved customer service and efficiency levels  the introduction of new product lines and the further promotion of its consolidation advantage program cap however  no assurances can be given that such steps will produce sufficient revenues in to cover the decrease in revenues to apria 
no other single customer or buying group accounted for more of the company s revenues in subsequent events on march   the company sold its gentle expressions breast pump product line to the lumiscope company  inc for a purchase price of  of which  was paid in cash with the balance in a secured subordinated promissory note payable over months plus interest at the prime rate of interest plus 
under the terms of the transaction  lumiscope will purchase certain inventory of the gentle expressions breast pump product line over a six month period  and provide the company with a one year royalty based upon lumiscope s sales to a certain retail discount chain 
in addition  the company entered into a supply agreement with lumiscope pursuant to which lumiscope will continue to supply the company with the gentle expressions breast pump product line for resale to the export market and certain other accounts 
effective as of march   the company formed a new entity  graham field express  inc  which operates from the company s distribution and warehouse facility located in mount vernon  new york 
graham field express provides same day and next day service of incontinence products  nutritionals  patient aids  wound care dressing solutions  and home healthcare products in the metropolitan new york area 
graham field express enables the company to compete more aggressively in the metropolitan new york home healthcare market 
f schedule ii valuation and qualifying accounts graham field health products  inc 
and subsidiaries col 
a col 
b col c 
col 
d col 
e additions balance at additions other changes balance beginning charged to costs charged to other add deduct at end of description of period and expenses accounts describe describe period allowance for doubtful accounts year ended december       year ended december      year ended december      net write offs of accounts receivable 
represents an allocation of the purchase price of national medical excess  corp 
f 
